Etoricoxib, Osteoarthritis 99% BAIYU
GMP 3 Inquiries
202409-33-4
Pharmaceutical Grade
99%
Shanghai
BAIYU
please consult for info
2022-12-31
Edaravone API,Ropivacaine Mesylate,Ambroxol,Pantoprazole Sodium,Enoxaparin Sodium,Clindamycin Phosphate
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceEtoricoxib is a non steroidal anti-inflammatory agent, acting as a selective and orally active COX-2 inhibitor, with IC50s of 1.1 μM and 116 μM for COX-2 and COX-1 in human whole blood.
Solid
Etoricoxib is a member of the class of bipyridines that is 2,3'-bipyridine which is substituted at the 3, 5, and 6' positions by 4-(methylsulfonyl)phenyl, chlorine, and methyl groups, respectively. It has a role as a cyclooxygenase 2 inhibitor and a non-steroidal anti-inflammatory drug. It is a sulfone, a member of bipyridines and an organochlorine compound.|Etoricoxib is a new COX-2 selective inhibitor. Current therapeutic indications are: treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout. Like any other COX-2 selective inhibitor, Etoricoxib selectively inhibits isoform 2 of cyclo-oxigenase enzyme (COX-2) to reduce the generation of prostaglandins (PGs) from arachidonic acid. It is approved in more than 60 countries worldwide but not in the US.|Etoricoxib is a synthetic, nonsteroidal anti-inflammatory drug (NSAID) with antipyretic, analgesic, and potential antineoplastic properties. Etoricoxib specifically binds to and inhibits the enzyme cyclooxygenase-2 (COX-2), resulting in inhibition of the conversion of arachidonic acid into prostaglandins. Inhibition of COX-2 may induce apoptosis and inhibit tumor cell proliferation and angiogenesis.|A sulfone and pyridine derivative that acts as a cyclooxygenase-2 inhibitor. It is used as a NSAID for the treatment of pain associated with RHEUMATOID ARTHRITIS and ANKYLOSING SPONDYLITIS. It is also used for the short-term treatment of moderate postoperative dental pain.CertificatesBasic Info-
Product Name:
Etoricoxib
Other Name:2,3′-Bipyridine,5-chloro-6′-methyl-3-[4-(methylsulfonyl)phenyl]-;5-Chloro-6′-methyl-3-[4-(methylsulfonyl)phenyl]-2,3′-bipyridine;Etoricoxib;MK 663;MK 0663;Arcoxia;Torcoxia;Kingcox;Etocox;Etobrix;Etoxib;Etropain;Algix;Tauxib;Nucoxia;Etosaid
CAS No.:202409-33-4
Molecular Formula:C18H15ClN2O2S
InChIKeys:InChIKey=MNJVRJDLRVPLFE-UHFFFAOYSA-N
Molecular Weight:358.84
Exact Mass:358.84
EC Number:1592732-453-0
UNII:WRX4NFY03R
DSSTox ID:DTXSID3046457
NCI Thesaurus Code:C52188
ATC Code:M01AH05|M - Musculo-skeletal system
HScode:2933399090
Categories:
Characteristics-
PSA:
68.3
XLogP3:3.3
Appearance:Solid
Density:1.3±0.1 g/cm3
Melting Point:134-135°C
Boiling Point:510°C at 760 mmHg
Flash Point:262.2±30.1 °C
Refractive Index:1.601
Water Solubility:3.28e-03 g/L
Storage Conditions:-20°C Freezer
Vapor Pressure:5.17E-10mmHg at 25°C
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 4, Oral
Acute toxicity - Category 2, Dermal
GHS label elements, including precautionary statements
Pictogram(s)
Signal word Danger
Hazard statement(s) H302 Harmful if swallowed
H310 Fatal in contact with skin
Precautionary statement(s) Prevention P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
P262 Do not get in eyes, on skin, or on clothing.
P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
Response P301+P317 IF SWALLOWED: Get medical help.
P330 Rinse mouth.
P302+P352 IF ON SKIN: Wash with plenty of water/...
P316 Get emergency medical help immediately.
P321 Specific treatment (see ... on this label).
P361+P364 Take off immediately all contaminated clothing and wash it before reuse.
Storage P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Edaravone API,Ropivacaine Mesylate,Ambroxol,Pantoprazole Sodium,Enoxaparin Sodium,Clindamycin Phosphate
-
Location:
10th Floor, Building B7, Tianfu Life Science Park, Life Science Park, South Keyuan Road, Wuhou District, Chengdu, P.R.China
-
Payment Terms:
TT against copy of documents,L/C
-
Average lead Time:
10 days
-
Total Annual Revenue:
$10 million-$25 million
-
Total Employees:
Above 1000
-
Year of Establishment:
2005
-
-
Inquiry History3 Inquiries
Country Product Purchase Quantity Date Posted
India
etoricoxib
500.00 KG Apr 9, 2024
Egypt
Etoricoxib
10 KG Jul 29, 2024
India
Etoricoxib
500.00 KG Apr 7, 2024 Post an enquiry for this product
More from this Seller
-
-
-
Azithromycin for Injection 0.25% or 0.5% white or off-white cake or powder lyophilized powder BAIYU
Pharmaceutical Grade / 99%
-
-
-
-
Ticagrelor 99% BAIYU
Pharmaceutical Grade / 99%
-
-
-
-
Tigecycline, Antibacterial 99% BAIYU
Pharmaceutical Grade / 99%
-
-
-
-
Enoxaparin Sodium Injection 0.6% BAIYU
Pharmaceutical Grade / 99%
$100-130/KG EXW
-
-
-
-
Clindamycin Phosphate for Injection 0.3% or 0.6% white or off-white cake or powder lyophilized powder BAIYU
Pharmaceutical Grade / 99%
$100-130/KG EXW
-
-
-
-
Pramipexole dihydrochloride, Parkinson's disease 99% BAIYU
Pharmaceutical Grade / 99%
-

